Hims & Hers Health announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical companies, medtech innovators, policymakers, and regulators, with the goal of paving the way to the healthcare of the future – where the power of technology will be combined with the best of personalized care. She will lead the company’s global public policy, regulatory, and government affairs functions.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Sell Rating on Hims & Hers Health Due to Overvaluation and Growth Concerns
- Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform
- Mixed options sentiment in Hims and Hers Health with shares down 6.37%
- Hims & Hers launches Labs in-depth testing experience
- Hims & Hers sees lab testing as $1B business, WSJ reports